SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
BHP Shares Fall as Jansen Potash Project Costs Surge 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
Trump Says Anthropic No Longer Seen as National Security Threat 
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC), a leading developer and marketer of innovative and proprietary products for healthy living applications in the food and biomedical markets, has been invited to present at the Wedbush Securities California Dreamin’ Management Access Conference. The conference is being held on December 9-10, 2015 at the Loews Santa Monica Hotel in Santa Monica, CA.
Landec CFO Greg Skinner is scheduled to present on Wednesday, December 9 at 1 p.m. Pacific time. He will discuss Landec's businesses, market leadership and progress.
For additional information or to schedule a one-on-one meeting with Landec management, please contact your Wedbush representative.
About Landec Corporation
Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec’s subsidiary, Apio, has become the leader in U.S. fresh-cut specialty packaged vegetables sold in North America based on combining Landec’s proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the company, visit Landec’s website at www.landec.com.
Contact Information: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: Matt Glover (949) 574-3860 [email protected]
